Published in: Clinical and experimental hypertension (New York, N.Y. : 1993) (2024)
Our findings indicated that SIRT5-mediated PRKAA2 succinylation modulates placental cell apoptosis in HDCP, suggesting that PRKAA2 is a potential therapeutic target for HDCP treatment.